CD7 and acute lymphoblastic leukemia: Base-editing of healthy donor T cells transduced to express a CAR with specificity for CD7 is being evaluated in a phase 1 pediatric trial of T-ALL, with preliminary results in three children showing molecular remission and subsequent transplant in two, and fatal fungal complications in one patient (14).